Delivery Order SPE2DR25D1202-SPE2DR26F72AG
- Not listed
- The Defense Logistics Agency awarded a $4,168.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of developmental viscosurgical coated ophthalmic products containing 4% chondroitin. The contract is categorized as a child award under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA and represents a non-competitive set-aside transaction. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML medical devices. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 19, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $20,449.42 delivery order to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.75ML) on October 27, 2025, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,500.68 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5ML) under a firm fixed-price contract type. The award was made on October 29, 2025, with an ultimate completion date of October 30, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed-price contract. The order, issued on September 26, 2025, with completion targeted for September 29, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $8,581.43 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML, with an ultimate completion date of September 24, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement and represents a single delivery order issued under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The awardee, headquartered in Conshohocken, Pennsylvania, is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,415.61 firm fixed-price delivery order is for the development and supply of VSCELAS 27GA VISCOAT 4% CHONDROITIN, a medical product. The contract has an ultimate completion date of June 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,172.83 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed-price contract. The order, awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $11,024.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Duovisc Viscoelastic System 1.05ML, a ophthalmic surgical product used in eye procedures. This non-competitive delivery order was issued on September 10, 2025, with an ultimate completion date of September 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order, this award derives from AmerisourceBergen's larger...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72AGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp for the development and supply of VSCELAS 27GA Viscoat with 4% Chondroitin on November 7, 2025. This firm fixed-price delivery order, which is set to be completed by November 10, 2025, represents a pediatric ophthalmic pharmaceutical product to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procedures with no set-aside designation, demonstrating AmerisourceBergen's capability to compete for specialized medical supplies within the federal procurement environment. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, maintains an extensive portfolio of drug and medical supply deliveries across multiple therapeutic domains. The company's federal contract awards consistently demonstrate its role in supplying specialized medications, generic drugs, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/7/25 |